This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Intercell Ag. Active years: 2009-2013.
Company Filing History:
Years Active: 2009-2013
Title: Shailesh Dewasthaly: Innovator in Nucleic Acid Technologies
Introduction
Shailesh Dewasthaly is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid technologies. With a total of 2 patents to his name, Dewasthaly's work has the potential to impact various applications in medicine and research.
Latest Patents
Dewasthaly's latest patents focus on isolated nucleic acid molecules that encode hyperimmune serum reactive antigens. These inventions detail methods for isolating such antigens and their specific uses. The innovative nature of his work highlights the importance of nucleic acids in developing therapeutic solutions.
Career Highlights
Shailesh Dewasthaly is currently associated with Intercell AG, a company known for its advancements in vaccine development and immunotherapy. His role at Intercell AG allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Dewasthaly has worked alongside notable colleagues such as Andreas Meinke and Markus Hanner. These collaborations have fostered an environment of innovation and have led to the development of impactful technologies.
Conclusion
Shailesh Dewasthaly's contributions to the field of biotechnology through his patents and collaborations underscore his role as a key innovator. His work continues to pave the way for advancements in medical science and therapeutic applications.